Mike Ouimette, General Counsel & Corporate Sec'y at PLIANT THERAPEUTICS, INC. (PLRX), sold 15,302 shares at $26.74 ($407K) on 2023-04-03, disclosed to the SEC on 2023-04-03.
Scheduled sale ($407k) by General Counsel & Corporate Sec'y under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.52 | 4,874 | $129K | 31.7% |
| 2 | $26.52 | 4,874 | $129K | 31.7% |
| 3 | $26.74 | 2,677 | $72K | 17.6% |
| 4 | $26.74 | 2,677 | $72K | 17.6% |
| 5 | $27.46 | 200 | $5K | 1.3% |
| Total | $26.61 avg | 15,302 |
| $407K |
| 100% |
| Filing → |
| PLRX | SELL | 2024-01-19 | $179K | — | Filing → |
| PLRX | SELL | 2023-07-21 | $167K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $460K | — | Filing → |